Form 4 for CADL Candel Therapeutics, Inc.
Accepted 2025-06-26 00:00:00 ET · period of report 2025-06-25 · accession 0000950170-25-090191 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-06-26 | 2025-06-25 | CADL | PAPA JOSEPH C | Dir | A - Grant | $4.67 | +64.2K | 64.2K | New | +$300.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-25 | A | A | 64,239 | $4.67 | 64,239 | I By Joseph C. Papa Revocable Living Trust | — | — | (F2) Shares held by Joseph C. Papa Revocable Living Trust, which is wholly owned by a trust for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any. |